Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
Overview
A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Double
- Study Primary Completion Date: October 2002
Interventions
- Drug: MK0429
Participating in This Clinical Trial
Inclusion Criteria
- Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis Exclusion Criteria:
- Person has had a previous fracture – Person has rheumatoid arthritis. Person has has certain types of cancer – Person has donated blood or has been in another investigational study within the last 4 weeks
Gender Eligibility: Female
Minimum Age: 50 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Medical Monitor, Study Director, Merck Sharp & Dohme LLC
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.